Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY, Distributed by: Ma...

FDA Drug Recall #D-0387-2022 — Class II — January 14, 2022

Recall Summary

Recall Number D-0387-2022
Classification Class II — Moderate risk
Date Initiated January 14, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Mayne Pharma Inc
Location Greenville, NC
Product Type Drugs
Quantity 17,113 canisters

Product Description

Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY, Distributed by: Mayne Pharma Greenville, NC 27834, NDC 51862-604-50

Reason for Recall

CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.

Distribution Pattern

Nationwide within the United States

Lot / Code Information

Lot #: 32451 Exp. 03/2022; 32532 Exp. 04/2022; 32552 Exp. 05/2022; 32701 32733 Exp. 10/2022; 32855 Exp. 02/2023; 32872 Exp. 03/2023.

Other Recalls from Mayne Pharma Inc

Recall # Classification Product Date
D-1152-2022 Class II Clonidine Transdermal System, USP 0.3 mg/day, 4... Jun 9, 2022
D-0998-2020 Class II Carbidopa and Levodopa Tablets, USP 25 mg/250mg... Mar 2, 2020
D-1129-2018 Class III Oxycodone and Acetaminophen Tablets, USP, 5 mg*... Aug 21, 2018
D-0616-2018 Class III Fabior (tazarotene) Foam, 0.1%, 100 grams can, ... Mar 21, 2018
D-0098-2018 Class II Liothyronine Sodium Tablets, USP 25 mcg ,100-co... Nov 9, 2017

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.